|
CYTSA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78160000086081E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.49369999889049E-08 |
| Normal-vs-Stage2 |
7.91840000000654E-05 |
| Normal-vs-Stage3 |
1.37270000000189E-06 |
| Normal-vs-Stage4 |
2.7229000054696E-08 |
| Stage1-vs-Stage2 |
6.865400E-01 |
| Stage1-vs-Stage3 |
8.023200E-01 |
| Stage1-vs-Stage4 |
1.455360E-03 |
| Stage2-vs-Stage3 |
5.495200E-01 |
| Stage2-vs-Stage4 |
8.695200E-03 |
| Stage3-vs-Stage4 |
3.745800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.90239999975361E-07 |
| Normal-vs-AfricanAmerican |
5.68229996389391E-09 |
| Normal-vs-Asian |
2.33020000000028E-05 |
| Caucasian-vs-AfricanAmerican |
4.968800E-01 |
| Caucasian-vs-Asian |
1.302190E-01 |
| AfricanAmerican-vs-Asian |
9.533900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.00190000740241E-09 |
| Normal-vs-Female |
1.827490E-04 |
| Male-vs-Female |
4.827600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.26720000048763E-07 |
| Normal-vs-Extreme_Weight |
3.06440000041874E-07 |
| Normal-vs-Obese |
1.89387999999235E-05 |
| Normal-vs-Extreme_Obese |
7.71649999999902E-05 |
| Normal_Weight-vs-Extreme_Weight |
6.869200E-01 |
| Normal_Weight-vs-Obese |
7.810000E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.912200E-01 |
| Extreme_Weight-vs-Obese |
1.407030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.104200E-01 |
| Obese-vs-Extreme_Obese |
2.662400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.761310E-04 |
| Normal-vs-Age(41-60Yrs) |
2.36759999999725E-05 |
| Normal-vs-Age(61-80Yrs) |
3.10540004822002E-09 |
| Normal-vs-Age(81-100Yrs) |
1.79020000046215E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.595400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.972800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.528000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.526100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.517600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.181160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.05710000000803E-06 |
| Normal-VS-Type2 PRCC |
7.74047492768659E-13 |
| Normal-VS-KIRP CIMP |
2.198700E-04 |
| Normal-VS-Unclassified PRCC |
1.203980E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.202700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.749600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.486600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.783600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.110130E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.724800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.37320180068923E-11 |
| Normal-vs-N1 |
1.51270999999564E-05 |
| Normal-vs-N2 |
7.736900E-03 |
| N0-vs-N1 |
5.742000E-01 |
| N0-vs-N2 |
9.664800E-01 |
| N1-vs-N2 |
8.470600E-01 |
|
|
